Britain on Thursday launched a trial to assess the immune responses generated if doses of the Covid-19 vaccines from Pfizer and AstraZeneca are combined in a two-shot schedule. WATCH MORE: https://thestartv.com/c/newsSUBSCRIBE: https://cutt.ly/TheStarLIKE: https://fb.com/TheStarOnline